| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |